The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 21, 2021

Filed:

Mar. 22, 2017
Applicants:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, CN;

Lianyungang Runzhong Pharmaceutical Co., Ltd., Lianyungang, CN;

Centaurus Biopharma Co., Ltd., Beijing, CN;

Inventors:

Li Zhu, Beijing, CN;

Yanqing Yang, Beijing, CN;

Liguang Dai, Beijing, CN;

Xiaowei Duan, Beijing, CN;

Zhao Yang, Beijing, CN;

Hui Zhang, Beijing, CN;

Yuandong Hu, Beijing, CN;

Yong Peng, Beijing, CN;

Yongxin Han, Beijing, CN;

Rui Zhao, Lianyungang, CN;

Xin Tian, Lianyungang, CN;

Shanchun Wang, Lianyungang, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); C07D 203/24 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07D 203/24 (2013.01); C07D 401/12 (2013.01);
Abstract

An iridinesulfonamide compound having isocitrate dehydrogenase 1 (IDH1) inhibitory activity, pharmaceutically acceptable salts, solvates or hydrates thereof, a pharmaceutical composition, as well as use of the compound or the pharmaceutically acceptable salts, solvates or hydrates thereof, and the pharmaceutical composition thereof in treating IDH1 mutation induced cancer.


Find Patent Forward Citations

Loading…